Global MicroRNA Market 2012-2016

NEW YORK, Oct.16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global MicroRNA Market 2012-2016

http://www.reportlinker.com/p01698955/Global-MicroRNA-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

TechNavio's analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.

TechNavio's report, Global MicroRNA Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Alnylam Pharmaceuticals Inc., Exiqon A/S, and Santaris Pharma A/S.

Other vendors mentioned in the report are

Access Pharmaceuticals, Aegera Therapeutics Inc., Affymetrix Inc., Agilent Technologies, Antisense Pharma GmbH, Aparna Biosciences Corp., Applied Biological Materials Inc., Arrowhead Research Corp., AstraZeneca Pharmaceuticals LP, Asuragen Inc., Benitec Biopharma Ltd., BioCancell Therapeutics Inc., Biogen Idec Inc., CBC Comprehensive Biomarker Center GmbH, Clontech Laboratories Inc., Dicerna Pharmaceuticals Inc., Eli Lilly and Co., EMD4Biosciences, Expression Genetics Inc., F. Hoffman-La Roche AG, Fluidigm Corp., GeneCopoeia Inc., GenoSensor Corp., Gensignia Inc., Groove Biopharma, GlaxoSmithKline, HTG Molecular Diagnostics Inc., Idera Pharmaceuticals Inc., Illumina Inc., InteRNA Technologies B.V., Isis Pharmaceuticals Inc., LC Sciences Llc, Life Technologies Corp., Merck & Co. Inc., miRagen Therapeutics Inc., Mirna Therapeutics Inc., NanoString Technologies Inc., Norgen Biotek Corp., Novartis AG, Pfizer Inc., Phalanx Biotech Group, PhaseRx Inc., Prolias Technologies Inc., Qiagen N.V., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Rosetta Genomics Ltd., RXi Pharmaceuticals Corp., Sanofi U.S., Sarepta Therapeutics, Sigma-Aldrich Co. Llc, Silence Therapeutics Plc, Sirnaomics Inc., siRNAsense AS, Sylentis SA, Tacere Therapeutics Inc., Tekmira Pharmaceuticals Corp., Theradiag, Thermo Fisher Scientific Inc., and WaferGen Biosystems Inc.

Key questions answered in this report:

What will the market size be in 2016 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

01. Executive Summary

02. Scope of the Report

02.1 Market Overview

02.2 Product Offerings

03. Market Research Methodology

03.1 Market Research Process

03.2 Research Design

03.3 Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

06.1 Market Overview

07. Global MicroRNA Research Market

08. Global MicroRNA Market

08.1 Market Size and Forecast

08.2 Five Forces Analysis

09. Global MicroRNA Market Segmentation

09.1 Global MicroRNA Tools and Reagents Market

09.1.1 Market Size and Forecast

09.2 Global MicroRNA Therapeutics Market

09.2.1 Market Size and Forecast

09.3 Global MicroRNA Diagnostics Market

09.3.1 Market Size and Forecast

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.2 Key Vendor Ranking 2012

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Alnylam Pharmaceuticals Inc.

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 SWOT Analysis

19.2 Exiqon A/S

19.2.1 Business Overview

19.2.2 Business Segmentation

19.2.3 Key Information

19.2.4 SWOT Analysis

19.3 Santaris Pharma A/S

19.3.1 Business Overview

19.3.2 Business Segmentation

19.3.3 Key Information

19.3.4 SWOT Analysis

20. Other Reports in this Series

List of Exhibits Exhibit 1: Market Research Methodology

Exhibit 2: Market Segmentation

Exhibit 3: Market Segmentation by Geography

Exhibit 4: MicroRNA Research Publications

Exhibit 5: Models Employed for MicroRNA Research

Exhibit 6: Areas with MicroRNA Research

Exhibit 7: Global MicroRNA Market 2012-2016 (US$ million)

Exhibit 8: Global MicroRNA Market Segmentation

Exhibit 9: Global MicroRNA Market Segmentation 2012

Exhibit 10: Global MicroRNA Market Segmentation 2012-2016

Exhibit 11: Global MicroRNA Tools and Reagents Market 2012-2016 (US$ million)

Exhibit 12: Global MicroRNA Expression Profiling Market Segmentation by Type of Technology

Exhibit 13: Global MicroRNA Tools and Reagents Market Segmentation by Geography

Exhibit 14: Global MicroRNA Therapeutics Market 2012-2016 (US$ million)

Exhibit 15: Global MicroRNA Diagnostics Market 2012-2016 (US$ million)

Exhibit 16: Global MicroRNA Market Segmentation by Geography 2012

Exhibit 17: Business Segmentation of Alnylam Pharmaceuticals Inc.

Exhibit 18: Business segmentation of Exiqon A/S

Exhibit 19: Business Segmentation of Santaris Pharma A/S

To order this report: Global MicroRNA Market 2012-2016 http://www.reportlinker.com/p01698955/Global-MicroRNA-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.